Delivery Order SPE2DB20D1109-SPE2DB24FP52X
Award Date
7/18/24
Potential Completion Date
7/19/24
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,192.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,488.88, is a Firm Fixed Price Delivery Order for the supply of Medroxyprogesterone 150 mg/mL. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,584.08 firm-fixed-price delivery order is for the supply of 4566764107 MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through December 20, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of medroxyprogesterone, a prescription medication, with a ceiling value of $1,122.24 and a performance period through March 14, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This federal contract award, SPE2DB20D3505|SPE2DB25FT7F2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,254.68 firm fixed-price delivery order is for the supply of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a completion date of January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price valued at $1,717.80. The contract is for the provision of medroxyprogesterone 150 mg/ml, a pharmaceutical product, to support military healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that maintains Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,291.43, is for the supply of 4,568,078,632 milliliters of Medroxyprogesterone 150 mg/mL, a medication used for various medical conditions. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 29, 2025. There is no set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,456.09, is a delivery order for the supply of 4567726860 - Progesterone 100 mg Capsule 100s. The contract has an ultimate completion date of March 31, 2025 and uses a firm fixed price pricing type. This contract award is associated with AmerisourceBergen's larger Indefinite Delivery Contract...
This federal contract award, valued at $11,961.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,925,357 units of Progesterone 200 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Progesterone 100 mg capsules. The contract is a Delivery Order valued at $24,327.43 with a firm fixed price and an ultimate completion date of April 4, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the...